{"changes":[],"country":"US","description":"StrykaGen develops integrin-targeted therapeutics and companion diagnostics for rare muscle diseases like DMD, BMD, MDC1A, and LGMD. It serves patients with rare muscular dystrophies and the pharma partners that may license its assets. Lab facilities at the University of Nevada School of Medicine support both small-molecule and biologic discovery.","domain":"strykagen.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":39.52205,"lng":-119.808084,"location":"RENO, Nevada, USA","name":"STRYKAGEN CORPORATION","rounds":[{"amountQuarantined":false,"amountUsd":2000000,"currency":"USD","date":"2023-09-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"strykagen-com","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"strykagen.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://strykagen.com"},{"fact":"description","publisher":"strykagen.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://strykagen.com"}],"stage":null,"techStack":["Typekit","Adobe Fonts","Afterpay","Sentry","Spin.js","Squarespace","Squarespace Commerce","Stimulus","parallax.js","web-vitals","moment 0","@sentry/browser"],"totalRaisedUsd":1953245,"updatedAt":"2026-05-07"}